The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease
Authors:
- 13 April 2015
- journal article
- review article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 45 (4) , 985-1000
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease increasing in frequency as life expectancy of the world's population increases. There are an estimated 5 million diagnosed AD patients in the U.S. and 16 million worldwide with no adequate treatment presently available. New therapeutic approaches are needed to slow, and hopefully reverse, disease progression. This review summarizes available information regarding an overlooked therapeutic target that may offer a treatment to slow and hopefully halt AD, namely the hepatocyte growth factor (HGF)/c-Met receptor system. Activation of the c-Met receptor stimulates mitogenesis, motogenesis, morphogenesis, the ability to mediate stem cell differentiation and neurogenesis, and protects against tissue insults in a wide range of cells including neurons. This growth factor system has recently been shown to induce dendritic arborization and synaptogenesis when stimulated by a newly developed angiotensin-based analogue, N-hexanoic-Tyr-Ile-(6) amino hexanoic amide (Dihexa). This small molecule was derived from the pre-prototype molecule Nle 1 -angiotensin IV and has shown promise in facilitating the formation of new functional synaptic connections and augmenting memory consolidation in animal models of AD. Dihexa is a first-in-class compound that is orally active, penetrates the blood-brain barrier, and facilitates memory consolidation and retrieval. This angiotensin-based small molecule may be efficacious as a treatment for AD.Keywords
This publication has 124 references indexed in Scilit:
- Neurotrophins: Transcription and Translation2014
- Hepatocyte growth factor overexpression in the nervous system enhances learning and memory performance in miceJournal of Neuroscience Research, 2012
- Stromal factors SDF1α, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cellsJournal of Neuroscience Research, 2012
- A review of the effects of memantine on clinical progression in Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2011
- Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusionJournal of Neuroscience Research, 2010
- The brain angiotensin IV/AT4receptor system as a new target for the treatment of Alzheimer's diseaseDrug Development Research, 2009
- Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injuryJournal of Neuroscience Research, 2007
- The MET receptor tyrosine kinase in invasion and metastasisJournal of Cellular Physiology, 2007
- Signaling by hepatocyte growth factor in neurons is induced by pharmacological stimulation of synaptic activitySynapse, 2007
- Hepatocyte growth factor improved learning and memory dysfunction of microsphere‐embolized ratsJournal of Neuroscience Research, 2004